Efficacy and tolerance of frontline bevacizumab-based chemotherapy for advanced non-small cell lung cancer patients: a multicenter, phase IV study of the Hellenic Oncology Research Group (HORG)
Crossref DOI link: https://doi.org/10.1007/s00280-016-3094-7
Published Online: 2016-06-22
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Matikas, A.
,
Kentepozidis, Ν.
Ardavanis, A.
Vaslamatzis, M.
Polyzos, A.
Emmanouilides, Ch.
Katsaounis, P.
Koinis, F.
Xynogalos, S.
Christopoulou, A.
Ziras, N.
Tegos, Th.
Prinarakis, E.
Hatzidaki, D.
Georgoulias, V.
Kotsakis, A.
License valid from 2016-06-22